BEUDAMED
    12 results · 21ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    ATB ADVANCE PTA DILATATION CATHETER

    FDA 510(k)
    FDA Class 2 ·Cardiovascular

    Aveta Waste Management Accessory

    FDA UDI
    MEDITRINA, INC.·00850006759699·Aveta Waste Management Accessory for use with A...

    Intelliguides

    FDA UDI
    Mios Marketing, LLC·G2710400520360·Anterior Dome Osteotomy Guide, 52mm x 36mm

    OSI MEDICAL DOLPHIN STAND-ALONE PULSE OXIMETER, MODEL 2100 AND DIGITAL DOLPHIN OPTICAL SENSOR, CLIP-ON FINGER PROBE, MOD

    FDA 510(k)
    FDA Class 2 ·Cardiovascular

    SIEMENS VIRTUAL SIMULATION (VSIM)

    FDA 510(k)
    FDA Class 2 ·Radiology

    BD INTIMA-II Y 22GAX1.00IN PRN EC SLM

    FDA Adverse Event
    Malfunction ·BD SUZHOU (MDS)·Product code FOZ·August 26, 2024

    BD VACUTAINER® SST¿ II ADVANCE PLUS BLOOD COLLECTION TUBES

    FDA Adverse Event
    Malfunction ·BECTON, DICKINSON AND COMPANY (BD)·Product code JKA·July 10, 2019

    ADMIRAL XTREME

    FDA Adverse Event
    Malfunction ·INVATEC SPA·Product code LIT·April 11, 2013

    CONTINUOUS NERVE BLOCK KIT: 19 GA X 24 IN

    FDA Adverse Event
    Malfunction ·ARROW INTL., INC.·Product code CAZ·March 2, 2011

    ACCU-CHEK COMFORT CURVE TEST STRIPS

    FDA Adverse Event
    Malfunction ·ROCHE DIAGNOSTICS·Product code LFR·May 21, 2008

    HEARTWARE VENTRICULAR ASSIST SYSTEM - SEWING RING

    FDA Adverse Event
    Malfunction ·HEARTWARE, INC.·Product code DSQ·May 8, 2018

    Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

    FDA Enforcement
    Class II ·Terminated·St Jude Medical Inc.·October 25, 2017